PE firm sells German ophthalmology group for 3.6 times return — 4 insights

Private equity firm Palamon Capital Partners sold its stake in Furth, Germany-based ophthalmology group Ober Scharrer for 3.6 times its initial investment, Private Equity News reports.

Advertisement

Here’s what you should know.

1. Palamon acquired a majority stake in the 80-clinic ophthalmology practice in 2011.

2. The clinic employs approximately 900 people and provides more than 85,000 treatments annually.

3. Palamon didn’t disclose the transactions’ exact financial figures.

4. A Palamon spokesperson said, “Robust demand driven by an ageing population and a number of add-ons [and] acquisitions have helped Ober triple its revenue, earnings and number of clinics since 2011.”

More articles on transactions/valuations: 
UnitedHealth Group eyes 2nd ambulatory acquisition & more — 9 ASC company key notes
6 things to know about IBS
Oregon House passes extended recovery stay bill, allows ASC patients to stay 48 hours

At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.

Advertisement

Next Up in ASC Transactions & Valuation Issues

Advertisement

Comments are closed.